Cited by 2,089Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Human Fatty Liver Disease: Old Questions and New Insights

Open access

Cohen, Jonathan C., Horton, Jay D., Hobbs, Helen H.·2011·Science

DOI 10.1126/science.1204265PMC PMC3229276

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.1204265

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citation
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citation
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citation
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Self-citation
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
Zimmermann, R., Bogner‐Strauß, J. G., Haemmerle, G., Schoiswohl, G., Birner‐Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,121
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Self-citation
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C. R., & Behling, C. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1212 · Cited by 1,477

Flagged first, then by citations

Show all 53 references

1 of the 53 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 1,007

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Kitabatake, H., Tanaka, N., Fujimori, N., Komatsu, M., Okubo, A., Kakegawa, K., Kimura, T., Sugiura, A., Yamazaki, T., Shibata, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i4.712 · Cited by 53
Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease
Pang, L., Liu, K., Liu, D., Lv, F., Zang, Y., Xie, F., Yin, J., Shi, Y., Wang, Y., & Chen, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0136-y · Cited by 54
SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation
Pan, Z.-G., & An, X.-S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.115 · Cited by 50
Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy
Pillai, S., Mahmud, I., Mahar, R., Griffith, C., Langsen, M., Nguyen, J. V., Wojtkowiak, J. W., Swietach, P., Gatenby, R. A., Bui, M. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110796 · Cited by 52
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity
Cheng, D., Zinker, B. A., Luo, Y., Shipkova, P. A., Oliveira, C. H. D., Krishna, G., Brown, E. A., Boehm, S., Tirucherai, G., Gu, H., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.007 · Cited by 55
Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
Okazaki, I., Noro, T., Tsutsui, N., Yamanouchi, E., Kuroda, H., Nakano, M., Yokomori, H., & Inagaki, Y. (2014) · Cancers · doi:10.3390/cancers6031220 · Cited by 55
Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease
Rossi, F., Bellini, G., Alisi, A., Alterio, A., Maione, S., Perrone, L., Locatelli, F., del Giudice, E. M., & Nobili, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042259 · Cited by 52
Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
Wolfs, M. G. M., Gruben, N., Rensen, S. S., Verdam, F. J., Greve, J.-W. M., Driessen, A. L. C., Wijmenga, C., Buurman, W. A., Franke, L., Scheja, L., et al. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2014.43 · Cited by 52
Elevated Plasma Retinol-Binding Protein 4 Is Associated with Increased Risk of Type 2 Diabetes in Middle-Aged and Elderly Chinese Adults
Sun, L. D., Qi, Q., Zong, G., Ye, X., Li, H., Liu, X., Zheng, H., Hu, F. B., Liu, Y., & Lin, X. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189860 · Cited by 53
The adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
Dietary Flaxseed Oil Prevents Western‐Type Diet‐Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein‐E Knockout Mice
Han, H., Qiu, F., Zhao, H., Tang, H., Li, X., & Shi, D. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3256241 · Cited by 53
Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden
Reddy, P., Leong, J., & Jialal, I. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.02.005 · Cited by 53
NURR1 activation in skeletal muscle controls systemic energy homeostasis
Amoasii, L., Sanchez‐Ortiz, E., Fujikawa, T., Elmquist, J. K., Bassel‐Duby, R., & Olson, E. N. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902490116 · Cited by 50
In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach
Tabernilla, A., Rodrigues, B. D. S., Pieters, A., Caufriez, A., Leroy, K., Campenhout, R. V., Cooreman, A., Gomes, A. R., Arnesdotter, E., Gijbels, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095038 · Cited by 54
miR ‐21‐5p promotes NASH ‐related hepatocarcinogenesis
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Islam, T., Gaspar, M. M., O’Rourke, C. J., Lewińska, M., Andersen, J. B., Arretxe, E., Alonso, C., et al. (2023) · Liver International · doi:10.1111/liv.15682 · Cited by 52
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
Lei, Z., Yu, J., Wu, Y. Z., Shen, J., Lin, S., Xue, W., Mao, C., Tang, R., Sun, H., Qi, X., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.025 · Cited by 51
Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
Sorrentino, G., Crispino, P., Coppola, D., & de Stefano, G. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0084-x · Cited by 50
PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans
Peter, A., Kovářová, M., Nadalin, S., Cermak, T., Königsrainer, A., Machicao, F. E., Stefan, N., Häring, H., & Schleicher, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3310-0 · Cited by 51
Analysis of the liver lipidome reveals insights into the protective effect of exercise on high-fat diet-induced hepatosteatosis in mice
Jordy, A. B., Kraakman, M. J., Gardner, T., Estévez, E., Kammoun, H. L., Weir, J. M., Kiens, B., Meikle, P. J., Febbraio, M. A., & Henstridge, D. C. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2014 · Cited by 51
Potential role ofHelicobacter pyloriinfection in nonalcoholic fatty liver disease
Li, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.7024 · Cited by 51
New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
López-Riera, M., Conde, I., Tolosa, L., Zaragoza, A., Castell, J. V., Gómez-Lechón, M. J., & Jover, R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00003 · Cited by 50
Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD
Araujo, L. C. C., Feitosa, K. B., Murata, G. M., Furigo, I. C., Teixeira, S. A., Lucena, C. F., Ribeiro, L. M., Muscará, M. N., Costa, S. K. P., Donato, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29044-y · Cited by 61
A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation
Bulutoglu, B., Rey-Bedón, C., Kang, Y. B., Mert, S., Yarmush, M. L., & Usta, O. B. (2019) · Lab on a Chip · doi:10.1039/c9lc00354a · Cited by 52
Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
Xu, L., Nagata, N., & Ota, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235920 · Cited by 51
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Steensels, S., Qiao, J., & Ersoy, B. A. (2020) · Metabolites · doi:10.3390/metabo10070283 · Cited by 53
Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy
Liu, J.-X., Zhang, T., Zhu, J.-Z., Ruan, S., Li, R.-S., Guo, B., & Lin, L.-G. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00528-w · Cited by 34
Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Doğru, T., Genç, H., Tapan, S., Erçin, C. N., Örs, F., Aslan, F., Kara, M., Sertoğlu, E., Bağcı, S., Kurt, İ., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.11.022 · Cited by 51
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
Noureddin, M., Anstee, Q. M., & Loomba, R. S. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13620 · Cited by 50
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Uehara, K., Sostre‐Colón, J., Gavin, M. J., Santoleri, D., Leonard, K., Jacobs, R. L., & Titchenell, P. M. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.015 · Cited by 54
Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders
Rajas, F., Labrune, P., & Mithieux, G. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.03.002 · Cited by 58
Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease
Jin, J., Valanejad, L., Nguyen, T. P., Lewis, K., Wright, M., Cast, A. E., Stock, L., Timchenko, L., & Timchenko, N. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.019 · Cited by 50
Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice.
Liu, X., Zhang, P., Martin, R. C. G., Cui, G., Wang, G., Tan, Y., Cai, L., Lv, G., & Li, Y. (2016) · PubMed Central · Cited by 50
Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States
Selvakumar, P. K. C., Kabbany, M. N., López, R., Rayas, M. S., Lynch, J. L., & Alkhouri, N. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001974 · Cited by 50
Immune Cell Trafficking to the Liver
Chaudhry, S., Emond, J. C., & Griesemer, A. (2019) · Transplantation · doi:10.1097/tp.0000000000002690 · Cited by 51
Insulin activates intracellular transport of lipid droplets to release triglycerides from the liver
Kumar, M., Ojha, S., Rai, P., Joshi, A., Kamat, S. S., & Mallik, R. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201903102 · Cited by 50
Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet
Abdulrahman, A. O., Kuerban, A., Alshehri, Z. A., Abdulaal, W. H., Khan, J. A., & Khan, M. I. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s268146 · Cited by 50
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
Cuthbertson, D. J., Koskinen, J. M., Brown, E. E., Magnussen, C. G., Hutri‐Kähönen, N., Sabin, M. A., Tossavainen, P. H., Jokinen, E. V., Laitinen, T. P., Viikari, J. S. A., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1956685 · Cited by 50
NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression?
Yilmaz, Y. N. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1306422 · Cited by 49
Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice
Gruben, N., Aparicio-Vergara, M., Kloosterhuis, N., van der Molen, H., Stoelwinder, S., Youssef, S. A., de Bruin, A., Delsing, D. J. M., Kuivenhoven, J. A., van de Sluis, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096345 · Cited by 50
Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
Gao, L., Wang, P., Zhang, Y., Yu, C., Ji, Y., Wang, X., Zhang, P., Jiang, X., Jin, H., Huang, Z., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.006 · Cited by 49
Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells
Vergani, L., Vecchione, G., Baldini, F., Grasselli, E., Voci, A., Portincasa, P., Ferrari, P. F., Aliakbarian, B., Casazza, A. A., & Perego, P. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1464-5 · Cited by 49
Lipid Droplet Fusion in Mammary Epithelial Cells is Regulated by Phosphatidylethanolamine Metabolism
Cohen, B.-C., Raz, C., Shamay, A., & Argov-Argaman, N. (2017) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-017-9386-7 · Cited by 49
Cideb controls sterol‐regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites
Su, L., Zhou, L., Chen, F., Wang, H., Qian, H., Sheng, Y., Zhu, Y., Yu, H. J., Gong, X., Cai, L., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100156 · Cited by 48
Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review
Parry, S. A., & Hodson, L. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01281-6 · Cited by 50
Associations of serum n–3 and n–6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease
Mäkelä, T. N., Tuomainen, T., Hantunen, S., & Virtanen, J. K. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac150 · Cited by 52
Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line
Rial, S. A., Ravaut, G., Malaret, T., Bergeron, K., & Mounier, C. (2018) · Molecules · doi:10.3390/molecules23092315 · Cited by 49
The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice
Stachowicz, A., Wiśniewska, A., Kuś, K., Kiepura, A., Gębska, A., Gajda, M., Białas, M. B., Totoń‐Żurańska, J., Stachyra, K., Suski, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071552 · Cited by 48
Quercetin and its role in modulating endoplasmic reticulum stress: A review
Eisvand, F., Tajbakhsh, A., Seidel, V., Zirak, M. R., Tabeshpour, J., & Shakeri, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7283 · Cited by 50
Hyaluronic acid–tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis
Yang, J., Kong, W. H., Sung, D. K., Kim, H., Kim, T. H., Lee, K. C., & Hahn, S. K. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.10.002 · Cited by 47
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
Ip, B. C., & Wang, X. (2013) · Nutrients · doi:10.3390/nu6010124 · Cited by 47
A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease
Başar, Ö., Akbal, E., Köklü, S., Koçak, E., Tuna, Y., Ekız, F., Gültuna, S., Yılmaz, F. M., & Aydoğan, T. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.699097 · Cited by 47
Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
Kessler, S. M., Simon, Y., Gemperlein, K., Gianmoena, K., Cadenas, C., Zimmer, V., Pokorny, J., Barghash, A., Helms, V., van Rooijen, N., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045762 · Cited by 47
Leptin signaling molecular actions and drug target in hepatocellular carcinoma
Sun, Q., Jiang, N., & Sun, R. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s69004 · Cited by 48
The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia
Wu, X., Chen, K., & Williams, K. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544424 · Cited by 48
Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP‐1c in L‐02 Cells
Qin, S., Yin, J., & Huang, K. (2016) · Lipids · doi:10.1007/s11745-016-4160-y · Cited by 47
Mea6 controls VLDL transport through the coordinated regulation of COPII assembly
Wang, Y., Liu, L., Zhang, H., Fan, J., Zhang, F., Yu, M., Shi, L., Yang, L., Lam, S. M., Wang, H., et al. (2016) · Cell Research · doi:10.1038/cr.2016.75 · Cited by 47
Gene pathways associated with mitochondrial function, oxidative stress and telomere length are differentially expressed in the liver of rats fed lifelong on virgin olive, sunflower or fish oils
Varela‐López, A., Pérez-López, M. P., Ramírez-Tortosa, C. L., Battino, M. A., Granados-Principal, S. M., Ramirez-Tortosa, M. D. C., Ochoa, J. J., Ramírez, L. V., Giampieri, F., & Quiles, J. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.007 · Cited by 47
Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
Dali‐Youcef, N., Vix, M., Costantino, F., Saghire, H. E., Lhermitte, B., Callari, C., D’Agostino, J., Perretta, S., Paveliu, S., Gualtierotti, M., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1396 · Cited by 49
Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease
Chen, H. (2020) · Liver Research · doi:10.1016/j.livres.2020.02.004 · Cited by 50
Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
Peng, L., Wu, S., Zhou, N., Zhu, S.-L., Liu, Q., & Li, X. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02595-2 · Cited by 47
Inflammation and Cancer
Todoric, J., Umemura, A., Taniguchi, K., & Karin, M. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm027 · Cited by 46
Lipid metabolic adaption to long-term ambient PM2.5 exposure in mice
Yang, S., Chen, R., Zhang, L., Sun, Q., Li, R., Gu, W., Zhong, M., Liu, Y., Chen, L., Sun, Q., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116193 · Cited by 46
Mice Deficient in Sfrp1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism, and Enhanced Macrophage Infiltration
Gauger, K. J., Bassa, L. M., Henchey, E., Wyman, J., Bentley, B., Brown, M., Shimono, A., & Schneider, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078320 · Cited by 46
SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids
Tobita, T., Guzman‐Lepe, J., Takeishi, K., Nakao, T., Wang, Y., Meng, F., Deng, C., de l’Hortet, A. C., & Soto–Gutiérrez, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149344 · Cited by 47
Loss of CTRP5 improves insulin action and hepatic steatosis
Lei, X., Rodriguez, S., Petersen, P. S., Seldin, M. M., Bowman, C. E., Wolfgang, M. J., & Wong, G. W. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2016 · Cited by 46
Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
Jin, L., Wang, R., Zhu, Y., Zheng, W., Han, Y., Guo, F., Ye, F. B., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep17288 · Cited by 46
Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation
Lord, C. C., Ferguson, D., Thomas, G., Brown, A. L., Schugar, R. C., Burrows, A. C., Gromovsky, A. D., Betters, J. L., Neumann, C. K. A., Sacks, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.049 · Cited by 46
Red paprika (Capsicum annuum L.) and its main carotenoid capsanthin ameliorate impaired lipid metabolism in the liver and adipose tissue of high-fat diet-induced obese mice
Kim, J., Ha, T. Y., Kim, S., Lee, S., & Ahn, J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.044 · Cited by 50
Promising effect of Rosa damascena extract on high-fat diet-induced nonalcoholic fatty liver
Davoodi, I., Rahimi, R., Abdollahi, M. R., Farzaei, F., Farzaei, M. H., Memariani, Z., & Najafi, F. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.01.008 · Cited by 46
Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver
Choi, S., Kwon, S., Seok, S., Xiao, Z., Lee, K. W., KANG, Y. Y., Li, X., Shinoda, K., Kajimura, S., KEMPER, B. W., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00006-17 · Cited by 46
Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice
Akinrotimi, O., Riessen, R., VanDuyne, P., Park, J. E., Lee, Y., Wong, L., Zavacki, A. M., Schoonjans, K., & Anakk, S. (2017) · Hepatology · doi:10.1002/hep.29305 · Cited by 50
There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
Wrighton, P. J., Oderberg, I. M., & Goessling, W. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.05.002 · Cited by 44
Association Between Dietary Selenium Intake and the Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
Wu, J., Zeng, C., Yang, Z., Li, X., Lei, G., Xie, D., Wang, Y., Wei, J., & Yang, T. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1613271 · Cited by 46
hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis
Xiong, J., Liu, T., Mi, L., Kuang, H., Xiong, X., Chen, Z., Li, S., & Lin, J. D. (2019) · Hepatology · doi:10.1002/hep.30921 · Cited by 46
PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
Ray, S. B. (2019) · Adipocyte · doi:10.1080/21623945.2019.1607423 · Cited by 50
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial
Derosa, G., Guasti, L., D’Angelo, A., Martinotti, C., Valentino, M. C., Matteo, S. D., Bruno, G. M., Maresca, A. M., Gaudio, G. V., & Maffioli, P. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.846873 · Cited by 46
Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study
Zhu, J., He, M., Zhang, Y., Li, T., Liu, Y., Xu, Z., & Chen, W. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0466 · Cited by 45
Lean nonalcoholic fatty liver disease and sarcopenia
Chen, M., Cao, Y. Y., Ji, G., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217249 · Cited by 47
WAT is a functional adipocyte?
CHURCH, C. D., Horowitz, M. C., & Rodeheffer, M. S. (2012) · Adipocyte · doi:10.4161/adip.19132 · Cited by 49
Dietary patterns associated with magnetic resonance imaging–determined liver fat content in a general population study
Koch, M., Borggrefe, J., Barbaresko, J., Groth, G., Jacobs, G., Siegert, S., Lieb, W., Müller, M. J., Bosy‐Westphal, A., Heller, M., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070219 · Cited by 45
Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity
Hwang, K.-A., Hwang, Y.-J., Kim, G. R., & Choe, J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0871-5 · Cited by 46
Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGFβ-Smad3 pathway
Lytle, K. A., Depner, C. M., Wong, C. P., & Jump, D. B. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m061275 · Cited by 45
Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes
Loftfield, E., Freedman, N. D., Lai, G. Y., Weinstein, S. J., McGlynn, K. A., Taylor, P. R., Männistö, S., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0141 · Cited by 45
Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
Martín‐Sanz, P., Casado, M., & Boscá, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3572 · Cited by 44
Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization
Cheng, J., Liu, C., Hu, K., Greenberg, A. S., Wu, D., Ausman, L. M., McBurney, M. W., & Wang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.004 · Cited by 45
Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease
Li, D., Liu, J., Hua, X., Fu, H., Huang, F., Fei, Y.-B., Lu, W.-J., Shen, F., & Wang, P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.002 · Cited by 45
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
Rohr‐Udilova, N., Bauer, E., Timelthaler, G., Eferl, R., Stolze, K., Pinter, M., Seif, M., Hayden, H., Reiberger, T., Schulte‐Hermann, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24300 · Cited by 45
Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
Kaur, S., Rawal, P., Siddiqui, H., Rohilla, S., Sharma, S., Tripathi, D. M., Baweja, S., Hassan, M., Vlaic, S., Guthke, R., et al. (2019) · Cells · doi:10.3390/cells8101277 · Cited by 45
Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
Jichitu, A., BUNGAU, S. G., Stănescu, A. M. A., Vesa, C. M., Toma, M. M., Bustea, C., Iurciuc, S., Rus, M., Bacalbaşa, N., & Diaconu, C. C. (2021) · Diagnostics · doi:10.3390/diagnostics11040689 · Cited by 47
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis
Ren, M., Xu, H., Xia, H., Tang, Q., & Bi, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00504-1 · Cited by 45
Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact
Lin, C., Huang, X., Liu, H., & Wang, Y. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3772-z · Cited by 45
Tyrosol Attenuates High Fat Diet‐Induced Hepatic Oxidative Stress: Potential Involvement of Cystathionine β‐Synthase and Cystathionine γ‐Lyase
Sarna, L. K., Sid, V., Wang, P., Siow, Y. L., House, J. D., & Karmin, O. (2015) · Lipids · doi:10.1007/s11745-015-4084-y · Cited by 44
Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr−/− mouse model
Kuba, M., Matsuzaka, T., Matsumori, R., Saito, R., Kaga, N., Taka, H., Ikehata, K., Okada, N., Kikuchi, T., Ohno, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17604 · Cited by 46
Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
Kessler, S. M., Laggai, S., Wonterghem, E. V., Gemperlein, K., Müller, R., Haybaeck, J., Vandenbroucke, R. E., Ogris, M., Libert, C., & Kiemer, A. K. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00147 · Cited by 44
Ces3/TGH Deficiency Attenuates Steatohepatitis
Lian, J., Wei, E., Groenendyk, J., Das, S. K., Hermansson, M., Li, L., Watts, R., Thiesen, A., Oudit, G. Y., Michalak, M., et al. (2016) · Scientific Reports · doi:10.1038/srep25747 · Cited by 44
Mouse models of non‐alcoholic steatohepatitis: A reflection on recent literature
Haczeyni, F., Yeh, M. M., Ioannou, G. N., Leclercq, I. A., Goldin, R. D., Dan, Y. Y., Yu, J. Q., Teoh, N., & Farrell, G. C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14122 · Cited by 47
S100A4 protects mice from high-fat diet-induced obesity and inflammation
Hou, S., Jiao, Y., Yuan, Q., Zhai, J., Tian, T., Sun, K., Chen, Z., Wu, Z., & Zhang, J. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0067-y · Cited by 44
S-petasin inhibits lipid accumulation in oleic acid-induced HepG2 cells through activation of the AMPK signaling pathway
Guo, L., Kang, J., Park, Y. H., Je, B. I., Lee, Y. J., Kang, N. J., Park, S. Y., Hwang, D. Y., & Choi, Y. W. (2020) · Food & Function · doi:10.1039/d0fo00594k · Cited by 45
Ex vivo machine perfusion: current applications and future directions in liver transplantation
Michelotto, J., Gassner, J. M. G. V., Moosburner, S., Muth, V., Patel, M. S., Selzner, M., Pratschke, J., Sauer, I. M., & Raschzok, N. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-02014-7 · Cited by 44
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis
Matye, D. J., Wang, H., Luo, W., Sharp, R. R., Chen, C., Gu, L., Jones, K. L., Ding, W., Friedman, J. E., & Li, T. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.013 · Cited by 44

Authors: Cohen, J. C., Horton, J. D., & Hobbs, H. H.
Affiliations: The University of Texas Southwestern Medical Center (US)
Howard Hughes Medical Institute (US)
Corresponding author: Hobbs, Helen H.
ORCID: Cohen, Jonathan C.
Horton, Jay D.
Hobbs, Helen H.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2011-06-24
Volume: 332
Issue: 6037
Pages: 1519-1523
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1204265
PMC: PMC3229276
OpenAlex: W2065612971
Cited by: 2,089
References: 53
Citations by year: 2026: 38 · 2025: 88 · 2024: 103 · 2023: 118 · 2022: 139 · 2021: 152 · 2020: 168 · 2019: 158 · 2018: 166 · 2017: 170 · 2016: 153 · 2015: 171 · 2014: 143 · 2013: 171 · 2012: 122
FWCI: 17.33
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (P01 HL-20948, P01HL020948, RL1HL092550)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090066)
National Institute of Dental and Craniofacial Research (UL1DE019584, UL1DE109584)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic triglyceride accumulation, liver inflammation, liver cirrhosis, hepatocellular carcinoma, obesity, insulin resistance, NAFLD pathogenesis, genetic susceptibility, metabolic mechanisms
MeSH terms: Animals, Dietary Fats, Disease Models, Animal, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Obesity, Triglycerides, Disease Progression, Genetic Predisposition to Disease, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human Fatty Liver Disease: Old Questions and New Insights

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks